Immunity And Disease Articles & Analysis: This-Week
1 articles found
Unlike receptors with highly selective ligand pools, CCR1’s redundancy ensures robustness of immune response but complicates therapeutic targeting. Blocking CCR1 can blunt harmful inflammation but risks impairing protective immunity. Clinical Relevance: From Autoimmunity to Oncology In autoimmune diseases such as multiple sclerosis, ...